NewsBenzingaAwiqli di Novo Nordisk riceve l’approvazione della FDA come il primo e unico insulina settimanale per bambini di età pari o superiore a 10 anni con diabete di tipo 2 Awiqli di Novo Nordisk riceve l’approvazione della FDA come il primo e unico insulina settimanale per bambini di età pari o superiore a 10 anni con diabete di tipo 2 Benzinga 2026.10.23 18:24 (GMT+0) Open on Benzinga Other news Rep. Byron Donalds Sells Netflix Stock for Loss: Here’s What He’s Buying Instead StoneX Group Q4 EPS $0.66 Down From $0.70 YoY, Sales $1.461B Up From $1.202B YoY QUICK SPARK: Intel Stock Eyes Worst Two-Month Drop on Record After Triple-Digit Rally Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate WesBanco Raises Quarterly Cash Dividend From $0.38 To $0.39 Per Share Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029
Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate
Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029